STUDY | ACCR. GOAL |
R E G |
O P E N |
ARM | TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
---|---|---|---|---|---|---|---|---|---|---|
S1703-Met Breast, STM-monitoring v Usual Care | 739 | 1 | Y | 0 Screening | 512 | 72 | 35 | 20 | 5 | 1 |
512 | 72 | 35 | 20 | 5 | 1 | |||||
2 | Y | 1 Control (Usual Care) | 172 | 25 | 15 | 7 | 2 | 0 | ||
2 Intervention (STMDDM) | 174 | 28 | 16 | 6 | 2 | 0 | ||||
346 | 53 | 31 | 13 | 4 | 0 | |||||
S1912CD-CREDIT, Fin Counseling to reduce Fin Hardship | 326 | 1 | Y | 1 Financial Navigation | 131 | 85 | 42 | 17 | 4 | 0 |
2 Control | 137 | 90 | 45 | 23 | 12 | 1 | ||||
268 | 175 | 87 | 40 | 16 | 1 | |||||
S2108CD-Genomic Tumor Board vs Usual Practice | 1182 | 1 | Y | 1 Usual Practice | 513 | 276 | 145 | 85 | 30 | 6 |
2 EGTB Intervention | 596 | 355 | 142 | 65 | 19 | 3 | ||||
1109 | 631 | 287 | 150 | 49 | 9 | |||||
A231602C-Blood Cancer, Assess Financial Difficulty | 1 | T | 4 | 0 | 0 | 0 | 0 | 0 | ||
4 | 0 | 0 | 0 | 0 | 0 | |||||
ACCL16N1-Guideline Consistent Treatment AYA ALL | 1 | T | 54 | 0 | 0 | 0 | 0 | 0 | ||
54 | 0 | 0 | 0 | 0 | 0 | |||||